Ocugen Announces CSO to Present on Modifier Gene Therapy at Retina World Congress

MALVERN, Pa., May 02, 2024 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that Arun...

Related Keywords

,Tarun Upadhyay ,Ocugen Inc ,Head Of Communications ,Retina World Congress ,Linkedin ,Exchange Commission ,Panel Session ,Head Of Research Development ,Chief Scientific Officer ,Gene Therapy ,Marriott Harbor Beach ,Efficacy Results ,Retinitis Pigmentosa ,Private Securities Litigation Reform Act ,